Human molecular adaptations to fasting: Insights from proteomic analysis

FHS
March 6, 2024
11:02 am

Researchers investigate systemic proteome adaptations to one week of fasting in humans.

Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed’s Phase IIb Palliative Care Trial | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – December 17, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a Canadian manufacturer

December 17, 2024

What would Hippocrates think of these First Opinions?

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers,

November 2, 2024

Medicaid startup Waymark publishes study proving its program slashes ER visits

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.